Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment.
暂无分享,去创建一个
D. Gaudet | R. Weiss | R. Dufour | J. Bergeron | G. Hovingh | A. Torri | R. Pordy | D. Gipe | Feng Yang | Zhizhi Qing | M. Andisik